KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Interest Coverage Ratio (2023 - 2025)

Historic Interest Coverage Ratio for Travere Therapeutics (TVTX) over the last 9 years, with Q3 2025 value amounting to 8.9.

  • Travere Therapeutics' Interest Coverage Ratio rose 14440.15% to 8.9 in Q3 2025 from the same period last year, while for Sep 2025 it was 8.03, marking a year-over-year increase of 7477.74%. This contributed to the annual value of 28.91 for FY2024, which is 1557.09% up from last year.
  • Travere Therapeutics' Interest Coverage Ratio amounted to 8.9 in Q3 2025, which was up 14440.15% from 4.44 recorded in Q2 2025.
  • In the past 5 years, Travere Therapeutics' Interest Coverage Ratio registered a high of 8.9 during Q3 2025, and its lowest value of 49.73 during Q1 2024.
  • Its 3-year average for Interest Coverage Ratio is 22.87, with a median of 22.94 in 2024.
  • Per our database at Business Quant, Travere Therapeutics' Interest Coverage Ratio surged by 3386.91% in 2024 and then surged by 14440.15% in 2025.
  • Travere Therapeutics' Interest Coverage Ratio (Quarter) stood at 33.4 in 2023, then surged by 35.06% to 21.69 in 2024, then surged by 141.05% to 8.9 in 2025.
  • Its Interest Coverage Ratio was 8.9 in Q3 2025, compared to 4.44 in Q2 2025 and 14.72 in Q1 2025.